Xuewei Liu

Title: Xuewei Liu: Innovator in Melanocortin Receptor Ligands

Introduction

Xuewei Liu is a prominent inventor based in San Diego, California. She has made significant contributions to the field of pharmacology, particularly through her innovative work on melanocortin receptor ligands. Her research focuses on developing compounds that have potential therapeutic applications.

Latest Patents

Xuewei Liu holds a patent for her invention titled "Melanocortin receptor ligands." This patent describes compounds that comprise a 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring. The compounds, including all enantiomeric and diastereomeric forms and pharmaceutically acceptable salts thereof, have a specific formula. The preferred components of the formula include substituted aryl groups and cyclic hydrocarbyl units, which enhance the compounds' efficacy.

Career Highlights

Xuewei Liu is currently employed at The Procter & Gamble Company, where she continues to advance her research in the pharmaceutical sector. Her work has led to the development of innovative solutions that address various health issues. With her expertise, she has become a valuable asset to her team and the company.

Collaborations

Xuewei Liu collaborates with notable colleagues, including Frank Hallock Ebetino and Mark Gregory Solinsky. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Xuewei Liu is a dedicated inventor whose work on melanocortin receptor ligands showcases her commitment to advancing pharmaceutical science. Her contributions have the potential to impact the field significantly.